Freund John Gordon (CIK 1296771) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy SIBN (10,957 shares), Sell COLL (20 shares), Buy COLL (8,741 shares), Buy COLL (8,700 shares), Sell COLL (4,127 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | SI-BONE, Inc. (SIBN) | Director | Buy | 10,957 | $0 |
| 2026-05-20 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Sell | 20 | $681 |
| 2026-05-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Buy | 8,741 | $0 |
| 2026-05-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Buy | 8,700 | $143,463 |
| 2026-05-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Sell | 4,127 | $142,547 |
| 2025-08-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Sell | 11,659 | $400,603 |
| 2025-08-11 | SI-BONE, Inc. (SIBN) | Director | Sell | 12,132 | $193,991 |
| 2025-06-11 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Buy | 15,000 | $201,750 |
| 2025-06-11 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Sell | 6,601 | $202,123 |
| 2025-06-06 | SI-BONE, Inc. (SIBN) | Director | Buy | 8,675 | $0 |
| 2025-05-19 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | Buy | 9,791 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08